US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist
  • 23.460
  • +0.390+1.69%
Close 02/23 16:00 ET
  • 23.460
  • 0.0000.00%
Post 18:14 ET
1.04BMarket Cap-16224P/E (TTM)

Silence Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)2023/09/30
(Q2)2023/06/30
(Q1)2023/03/31
(FY)2022/12/31
(Q4)2022/12/31
(Q3)2022/09/30
(Q2)2022/06/30
(Q1)2022/03/31
(FY)2021/12/31
(Q4)2021/12/31
Total revenue
-17.00%2.8M
149.90%9.1M
98.78%11.37M
40.97%17.5M
39.57%4.77M
6.81%3.37M
34.88%3.64M
82.00%5.72M
126.59%12.42M
45.59%3.41M
Operating revenue
-17.00%2.8M
149.90%9.1M
98.78%11.37M
40.97%17.5M
39.57%4.77M
6.81%3.37M
34.88%3.64M
82.00%5.72M
126.59%12.42M
45.59%3.41M
Cost of revenue
-32.87%1.61M
20.37%2.83M
99.30%4.53M
45.92%10.88M
88.98%3.86M
16.67%2.39M
28.88%2.35M
48.02%2.28M
98.19%7.46M
42.70%2.04M
Gross profit
21.90%1.19M
385.90%6.27M
98.43%6.84M
33.51%6.62M
-33.97%906K
-11.50%977K
47.37%1.29M
114.50%3.45M
188.82%4.96M
50.11%1.37M
Operating expense
-4.85%13.89M
15.28%17.73M
42.04%18.99M
8.75%55.21M
-6.08%11.87M
9.04%14.6M
11.43%15.38M
22.11%13.37M
35.16%50.77M
-2.81%12.64M
Selling and administrative expenses
-14.95%4.96M
12.47%5.12M
11.86%6.45M
-1.99%19.61M
-35.91%3.47M
6.49%5.83M
-15.42%4.55M
53.80%5.77M
43.09%20.01M
-12.12%5.41M
-General and administrative expense
-14.95%4.96M
12.47%5.12M
11.86%6.45M
-1.99%19.61M
-35.91%3.47M
6.49%5.83M
-15.42%4.55M
53.80%5.77M
43.09%20.01M
-12.12%5.41M
Research and development costs
1.86%8.93M
16.46%12.62M
64.92%12.54M
15.73%35.61M
16.27%8.4M
10.80%8.77M
32.63%10.83M
1.94%7.6M
52.23%30.77M
10.09%7.22M
Operating profit
6.77%-12.7M
18.68%-11.46M
-22.45%-12.15M
-6.07%-48.59M
2.68%-10.96M
-10.88%-13.62M
-8.99%-14.09M
-6.22%-9.92M
-27.80%-45.81M
6.81%-11.26M
Net non-operating interest income expense
-52.55%2.04M
-182.66%-553K
-249.71%-524K
8,850.00%179K
-6,518.75%-5.14M
1,751.29%4.3M
205.48%669K
166.16%350K
-98.23%2K
110.27%80K
Non-operating interest income
-52.74%2.05M
-49.18%340K
-4.00%336K
2,160.00%226K
-256,200.00%-5.12M
1,362.50%4.33M
205.48%669K
17,400.00%350K
-92.25%10K
100.23%2K
Non-operating interest expense
-76.47%8K
--893K
--860K
487.50%47K
116.67%13K
-46.88%34K
--0
--0
-50.00%8K
24.27%-78K
Other net income (expense)
2,477.27%1.05M
85.67%-44K
Gain on sale of security
----
----
----
2,477.27%1.05M
----
----
----
----
85.67%-44K
----
Income before tax
-14.31%-10.66M
10.51%-12.01M
-32.40%-12.67M
-3.30%-47.37M
-34.05%-15.05M
22.62%-9.33M
-5.60%-13.42M
3.02%-9.57M
-27.23%-45.86M
14.77%-11.23M
Income tax
-8.46%-2.41M
-8.64%-1.61M
-30.77%-2.47M
-6.72%-6.88M
28.22%-1.29M
-4.71%-2.22M
-37.13%-1.48M
-30.21%-1.89M
-84.49%-6.45M
-144.95%-1.79M
Net income
-16.15%-8.25M
12.88%-10.4M
-32.80%-10.2M
-2.74%-40.49M
-45.89%-13.76M
28.46%-7.1M
-2.67%-11.94M
8.74%-7.68M
-21.09%-39.41M
24.16%-9.43M
Net income continuous Operations
-16.15%-8.25M
12.88%-10.4M
-32.80%-10.2M
-2.74%-40.49M
-45.89%-13.76M
28.46%-7.1M
-2.67%-11.94M
8.74%-7.68M
-21.09%-39.41M
24.16%-9.43M
Minority interest income
Net income attributable to the parent company
-16.15%-8.25M
12.88%-10.4M
-32.80%-10.2M
-2.74%-40.49M
-45.89%-13.76M
28.46%-7.1M
-2.67%-11.94M
8.74%-7.68M
-21.09%-39.41M
24.16%-9.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-16.15%-8.25M
12.88%-10.4M
-32.80%-10.2M
-2.74%-40.49M
-45.89%-13.76M
28.46%-7.1M
-2.67%-11.94M
8.74%-7.68M
-21.09%-39.41M
24.16%-9.43M
Basic earnings per share
-2.78%-0.222
27.82%-0.288
-10.47%-0.285
5.42%-1.257
-24.76%-0.393
35.14%-0.216
-1.53%-0.399
11.34%-0.258
-11.31%-1.329
30.46%-0.315
Diluted earnings per share
-2.78%-0.222
27.82%-0.288
-10.47%-0.285
5.42%-1.257
-24.76%-0.393
35.14%-0.216
-1.53%-0.399
11.34%-0.258
-11.31%-1.329
30.46%-0.315
Dividend per share
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)2023/09/30(Q2)2023/06/30(Q1)2023/03/31(FY)2022/12/31(Q4)2022/12/31(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31
Total revenue -17.00%2.8M149.90%9.1M98.78%11.37M40.97%17.5M39.57%4.77M6.81%3.37M34.88%3.64M82.00%5.72M126.59%12.42M45.59%3.41M
Operating revenue -17.00%2.8M149.90%9.1M98.78%11.37M40.97%17.5M39.57%4.77M6.81%3.37M34.88%3.64M82.00%5.72M126.59%12.42M45.59%3.41M
Cost of revenue -32.87%1.61M20.37%2.83M99.30%4.53M45.92%10.88M88.98%3.86M16.67%2.39M28.88%2.35M48.02%2.28M98.19%7.46M42.70%2.04M
Gross profit 21.90%1.19M385.90%6.27M98.43%6.84M33.51%6.62M-33.97%906K-11.50%977K47.37%1.29M114.50%3.45M188.82%4.96M50.11%1.37M
Operating expense -4.85%13.89M15.28%17.73M42.04%18.99M8.75%55.21M-6.08%11.87M9.04%14.6M11.43%15.38M22.11%13.37M35.16%50.77M-2.81%12.64M
Selling and administrative expenses -14.95%4.96M12.47%5.12M11.86%6.45M-1.99%19.61M-35.91%3.47M6.49%5.83M-15.42%4.55M53.80%5.77M43.09%20.01M-12.12%5.41M
-General and administrative expense -14.95%4.96M12.47%5.12M11.86%6.45M-1.99%19.61M-35.91%3.47M6.49%5.83M-15.42%4.55M53.80%5.77M43.09%20.01M-12.12%5.41M
Research and development costs 1.86%8.93M16.46%12.62M64.92%12.54M15.73%35.61M16.27%8.4M10.80%8.77M32.63%10.83M1.94%7.6M52.23%30.77M10.09%7.22M
Operating profit 6.77%-12.7M18.68%-11.46M-22.45%-12.15M-6.07%-48.59M2.68%-10.96M-10.88%-13.62M-8.99%-14.09M-6.22%-9.92M-27.80%-45.81M6.81%-11.26M
Net non-operating interest income expense -52.55%2.04M-182.66%-553K-249.71%-524K8,850.00%179K-6,518.75%-5.14M1,751.29%4.3M205.48%669K166.16%350K-98.23%2K110.27%80K
Non-operating interest income -52.74%2.05M-49.18%340K-4.00%336K2,160.00%226K-256,200.00%-5.12M1,362.50%4.33M205.48%669K17,400.00%350K-92.25%10K100.23%2K
Non-operating interest expense -76.47%8K--893K--860K487.50%47K116.67%13K-46.88%34K--0--0-50.00%8K24.27%-78K
Other net income (expense) 2,477.27%1.05M85.67%-44K
Gain on sale of security ------------2,477.27%1.05M----------------85.67%-44K----
Income before tax -14.31%-10.66M10.51%-12.01M-32.40%-12.67M-3.30%-47.37M-34.05%-15.05M22.62%-9.33M-5.60%-13.42M3.02%-9.57M-27.23%-45.86M14.77%-11.23M
Income tax -8.46%-2.41M-8.64%-1.61M-30.77%-2.47M-6.72%-6.88M28.22%-1.29M-4.71%-2.22M-37.13%-1.48M-30.21%-1.89M-84.49%-6.45M-144.95%-1.79M
Net income -16.15%-8.25M12.88%-10.4M-32.80%-10.2M-2.74%-40.49M-45.89%-13.76M28.46%-7.1M-2.67%-11.94M8.74%-7.68M-21.09%-39.41M24.16%-9.43M
Net income continuous Operations -16.15%-8.25M12.88%-10.4M-32.80%-10.2M-2.74%-40.49M-45.89%-13.76M28.46%-7.1M-2.67%-11.94M8.74%-7.68M-21.09%-39.41M24.16%-9.43M
Minority interest income
Net income attributable to the parent company -16.15%-8.25M12.88%-10.4M-32.80%-10.2M-2.74%-40.49M-45.89%-13.76M28.46%-7.1M-2.67%-11.94M8.74%-7.68M-21.09%-39.41M24.16%-9.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -16.15%-8.25M12.88%-10.4M-32.80%-10.2M-2.74%-40.49M-45.89%-13.76M28.46%-7.1M-2.67%-11.94M8.74%-7.68M-21.09%-39.41M24.16%-9.43M
Basic earnings per share -2.78%-0.22227.82%-0.288-10.47%-0.2855.42%-1.257-24.76%-0.39335.14%-0.216-1.53%-0.39911.34%-0.258-11.31%-1.32930.46%-0.315
Diluted earnings per share -2.78%-0.22227.82%-0.288-10.47%-0.2855.42%-1.257-24.76%-0.39335.14%-0.216-1.53%-0.39911.34%-0.258-11.31%-1.32930.46%-0.315
Dividend per share
Currency Unit GBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg